IP Library Granted Patent US 11,350,963
Granted Patent B2
US 11,350,963 · App. 16/555,019 · Granted Jun 7, 2022

Fluid jet tissue ablation apparatus

Inventors: Nikolai Aljuri (Hillsborough, CA); Edward Karpman (Los Altos, CA); Chris Danek (San Carlos, CA)
Assignee: PROCEPT BioRobotics Corporation
A61B17/3203A61B2017/00154A61B2017/00172A61B2017/00274A61B2017/32032A61B2017/32035A61B2018/00547
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,350,963
App. No.
16/555,019
Granted
Jun 7, 2022
Kind
B2
Abstract

An apparatus is configured to provide hemostasis with tissue removal in order to inhibit one or more of blood loss or tissue drainage. In many embodiments, a nozzle releases a liquid jet in a liquid medium in order to provide cavitation and a plurality of shedding pulses. The liquid jet, its cavitation and the plurality of shedding pulses can affect vascular tissue in order to promote clotting in order to inhibit bleeding. In many embodiments, vessels of the vascular tissue are affected at a distance from a region where cavitation of the water jet contacts the tissue. In many embodiments, the cavitation and plurality of shedding pules are related to a pulsatile shear wave propagating along the blood vessel that is related to clot promoting changes of the blood vessel.

Claims (17)

1. An apparatus to ablate vascular tissue, the apparatus comprising,

a pump;

a nozzle coupled to the pump, the nozzle sized for immersion in a liquid; and

circuitry coupled to the pump and the nozzle, the circuitry configured to provide a plurality of shedding pulses with a jet released into the liquid, the plurality of shedding pulses providing a pulsatile shear wave.

2. The apparatus of claim 1 , wherein the pump provides a flow rate and the nozzle is configured to provide the plurality of shedding pulses in order to provide the pulsatile shear wave extending a distance from a cut profile to an affected location of a blood vessel, and wherein the affected location promotes blood clotting.

3. The apparatus of claim 1 , wherein the nozzle is configured to be arranged with the tissue at a distance no more than a threshold transition distance from the tissue.

4. The apparatus of claim 1 , wherein the nozzle is configured to be arranged with the tissue at a distance greater than a threshold transition distance from the tissue.

5. The apparatus of claim 1 , further comprising a processor comprising instructions to treat the vascular tissue with the nozzle, the processor coupled to a linkage to move the nozzle in response to the instructions, wherein the processor comprises instructions to remove the tissue with a tissue removal profile with the nozzle positioned at a distance no more than a threshold transition distance for selective tissue removal from the tissue removal profile.

6. The apparatus of claim 1 , wherein the pump comprises a piston to deliver a plurality of pump pulses and wherein the nozzle and a flow rate of the pump are configured to provide a plurality of pump pulses and each of the plurality of pump pulses provides a plurality of shedding pulses.

7. The apparatus of claim 1 , further comprising a processor comprising instructions to treat the vascular tissue with the nozzle, the processor coupled to a linkage to move the nozzle in response to the instructions, wherein the processor comprises instructions to remove the tissue with a tissue removal profile with the nozzle positioned at a distance no more than a threshold transition distance from the tissue removal profile for selective tissue removal.

8. The apparatus of claim 1 , wherein the nozzle is configured to be arranged to be directed toward tissue to be cut, wherein jet hydrodynamic parameters are configured to allow mechanical disruption of the tissue, and wherein the jet hydrodynamic parameters are also configured to inhibit bleeding.

9. The apparatus of claim 8 , wherein the jet hydrodynamic parameters comprise one or more of a fluid jet velocity or a shear stress field, and/or wherein the jet hydrodynamic parameters are configured to control a cavitation field in order to cut the tissue with inhibited bleeding.

10. The apparatus of claim 1 , wherein the nozzle is configured to provide the jet and is directed toward the vascular tissue in the liquid to cut said tissue through mechanical interaction of the jet with the tissue, wherein bleeding of cut vessels within the tissue is inhibited by one or more of platelet aggregation or thrombus formation in response to one or more hydrodynamic parameters of the jet.

11. The apparatus of claim 1 , wherein the pulsatile shear wave extends a distance from a tissue removal profile to an affected location of a blood vessel, and wherein the pulsatile shear wave promotes hemostasis at the affected location.

12. The apparatus of claim 1 , wherein the jet comprises a substantially abrasive jet in order to remove vessels and non-vascular tissue of the vascular tissue at similar rates, and/or wherein the plurality of shedding pulses comprises substantially abrasive shedding pulses in order to remove vessels and non-vascular tissue of the vascular tissue at similar rates.

13. The apparatus of claim 1 , wherein the plurality of shedding pulses is configured to remove the vascular tissue along a removal profile and further configured to decrease bleeding at a distance from the removal profile.

14. The apparatus of claim 13 , wherein the plurality of shedding pulses is configured to decrease the bleeding of the vascular tissue with one or more of induced thrombosis in capillaries and arterioles related to endothelial injury, shear stress and reduction in blood flow, adhesion and aggregation of platelets, deposition of fibrin, deposition of fibrin related to obstructive vessel clotting, fluid pressure in an affected zone, fluid pressure in an affected zone at a distance from the removal profile, inhibited blood flow in affected blood vessels, partial collapse of the affected blood vessels, or full collapse of the affected blood vessels.

Assignments (3)
SECURITY INTEREST Recorded Oct 6, 2022
From: PROCEPT BIOROBOTICS CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 061623/0289 →
MERGER Recorded Apr 14, 2021
From: PROCEPT BIOROBOTICS CORPORATION
To: PROCEPT BIOROBOTICS CORPORATION
Reel/Frame 055941/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2019
From: ALJURI, NIKOLAI; DANEK, CHRIS; KARPMAN, EDWARD
To: PROCEPT BIOROBOTICS CORPORATION
Reel/Frame 050211/0911 →
Continuity (5)
Division 15388515 · Dec 22, 2016
Continuation PCTUS2015038605 · Jun 30, 2015
Provisional Application 62032958 · Aug 4, 2014
Provisional Application 62019299 · Jun 30, 2014
Related Publication 20190380730A1 · Dec 19, 2019
Cited By (1)
US 12,502,195